Another field of research is preparing formulas
and technology of production dermatologic drugs and cosmeceutics affecting skin diseases and inflammations,
as well wound healing.

Know-how

Intellectual property of the company consist of unique know-how about active compounds found in coffee researched by founders and technology of production of food and cosmetics containing those compounds.

Trigendo Ltd.'s intellectual property is protected by patent claims filled in 36 countries (following Patent Cooperation Treaty procedure).

The first patent was granted to Trigendo by US PTO covering US market. Patent No US 7,893,095 B2 granted February 22nd, 2011, secures Trigendo Ltd. exclusive rights to use quaternary pyridinium compounds for use in 17 separate therapeutic areas.

Our Mission

Trigendo Limited is innovative privately founded Polish biotech company, researching chemical compounds found in coffee that can be used as potential drugs.

Our Business

The company's main focus is on chemical, biochemical and pharmacological research leading to development of new drugs which can bring therapeutic effects in diseases associated with endothelial dysfunction. It may lead to treatment or prevention of many diseases of civilization, e.g.:

• liver injuries
• diabetes type 2
• atherosclerosis
• kidney degeneration
• obesity

Other company's activities include conducting research on functional food and food suplements that can beneficial when treating diseases caused by endothelial dysfunction.